Yahoo Malaysia Web Search

Search results

  1. Allergan is now part of AbbVie. We discover and develop innovative medicines for tomorrow, while helping people live better lives today.

    • Careers Job Search

      Allergan plc (NYSE: AGN) is a bold, global pharmaceutical...

    • Patients

      From drug discovery and development to ensuring our...

    • Pipeline

      AbbVie and Genmab will participate in the joint development...

    • Partner With Us

      AbbVie Ventures We strategically invest in transformational...

    • Science

      At AbbVie, our R&D teams are chasing bold goals. We are...

    • Sustainability

      2023 marked the close of our historic five-year, $350...

    • Accessibility Statement

      Please let us know if you encounter any accessibility issues...

    • News Center

      AbbVie (NYSE:ABBV) today announced that Roopal Thakkar, M.D....

  2. May 8, 2020 · AbbVie Completes Transformative Acquisition of Allergan. - Creates biopharmaceutical company with leadership positions in key therapeutic areas: Immunology, Hematologic Oncology, Neuroscience, and Allergan Aesthetics. - Robust portfolio of on-market and pipeline assets well-positioned for sustainable long-term growth.

  3. May 7, 2024 · That day, AbbVie officially closed its $63-billion acquisition of Allergan to create a larger, stronger and more diversified global biopharmaceutical company. It was an acquisition that allowed us to grow in numbers and bolster our ability to improve people’s lives worldwide.

  4. AbbVie has acquired Allergan to expand and diversify its product portfolio and R&D pipeline. Learn how this merger is transforming lives today and innovating for tomorrow.

  5. news.abbvie.com › 2020/05/08-AbbVie-Inc-CompletesAbbVie News Center - News

    May 8, 2020 · Allergan plc (NYSE: AGN) ("Allergan") announced that AbbVie has now completed the acquisition of Allergan pursuant to a scheme of arrangement under Chapter 1 of Part 9 of the Irish Companies Act 2014 (the "Scheme"), which became effective earlier today, May 8, 2020.

  6. AbbVie Completes Transformative Acquisition of Allergan. Creates biopharmaceutical company with leadership positions in key therapeutic areas: Immunology, Hematologic Oncology, Neuroscience, and Allergan Aesthetics. Robust portfolio of on-market and pipeline assets well-positioned for sustainable long-term growth.

  7. Jun 26, 2019 · AbbVie Inc. ABBV has entered into a definitive transaction agreement with Allergan AGN in a bid to acquire the latter in a cash and stock deal. AbbVie is offering $120.30 in cash and 0.866 of...